ETrade Capital Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$1.58M Buy
14,174
+2,301
+19% +$210K 0.03% 262
2020
Q2
$963K Buy
11,873
+1,648
+16% +$133K 0.02% 361
2020
Q1
$712K Buy
10,225
+7,553
+283% +$580K 0.02% 376
2019
Q4
$208K Buy
+2,672
New +$193K ﹤0.01% 764

Other funds holding GH

ETrade Capital Management's GH Position: Q3 2020 in Review

ETrade Capital Management increased its Guardant Health (GH) stake by 19% in Q3 2020, buying an estimated $210K and bringing the position to 14,174 shares worth $1.58M. The position accounts for 0.03% of the portfolio, ranked #262.

ETrade Capital Management first reported a position in GH in Q4 2019 and has held it in 4 quarters since. 346 funds tracked by Wall St. Rank hold GH as of Q3 2020.

  • ETrade Capital Management held 14,174 shares of Guardant Health worth $1.58M as of Q3 2020.
  • ETrade Capital Management bought 2,301 Guardant Health shares in Q3 2020, an estimated $210K.
  • Guardant Health made up 0.03% of ETrade Capital Management's portfolio in Q3 2020, its #262 holding.
  • ETrade Capital Management first reported a position in Guardant Health in Q4 2019 and has held it in 4 quarters since.
  • 346 funds tracked by Wall St. Rank held Guardant Health as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.